{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T02:43:46Z","timestamp":1792637026996,"version":"4.5.0"},"reference-count":53,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010250","name":"Sichuan Province Youth Science and Technology Innovation Team","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Controlled Release"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/j.jconrel.2019.09.021","type":"journal-article","created":{"date-parts":[[2019,10,16]],"date-time":"2019-10-16T12:25:50Z","timestamp":1571228750000},"page":"42-53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":112,"special_numbering":"C","title":["Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy"],"prefix":"10.1016","volume":"313","author":[{"given":"Xiao","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqiao","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingya","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6155-4010","authenticated-orcid":false,"given":"Shaobing","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jconrel.2019.09.021_bib0005","first-page":"394","article-title":"Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries","volume":"68","author":"Bray","year":"2018","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0010","first-page":"5","article-title":"Cancer statistics, 2015","volume":"65","author":"Siegel","year":"2015","journal-title":"CA Cancer J. Clin."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0015","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/adma.201303123","article-title":"MSN anti-cancer nanomedicines: chemotherapy enhancement, overcoming of drug resistance, and metastasis inhibition","volume":"26","author":"He","year":"2014","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0020","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.addr.2015.10.019","article-title":"\"Combo\" nanomedicine: Co-delivery of multi-modal therapeutics for efficient, targeted, and safe cancer therapy","volume":"98","author":"Kemp","year":"2016","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0025","doi-asserted-by":"crossref","first-page":"3822","DOI":"10.1021\/acs.nanolett.7b01193","article-title":"Spatial targeting of tumor-associated macrophages and tumor cells wit-h a pH-Sensitive cluster nanocarrier for Cancer chemoimmunotherapy","volume":"17","author":"Shen","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0030","doi-asserted-by":"crossref","first-page":"6366","DOI":"10.1021\/acs.nanolett.7b03186","article-title":"Tumor microenvironment responsive nanogel for the combinatorial antitumor effect of chemotherapy and immunotherapy","volume":"17","author":"Song","year":"2017","journal-title":"Nano Lett."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0035","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201800025","article-title":"iRGD modified chemo-immunotherapeutic nanoparticles for enhanced immunotherapyagainst glioblastoma","volume":"28","author":"Kuang","year":"2018","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0040","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1038\/nrclinonc.2016.25","article-title":"The future of cancer treatment:immunomodulation, CARs and combination immunotherapy","volume":"13","author":"Khalil","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0045","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1016\/j.biomaterials.2014.04.073","article-title":"Engineered, self-assemblednear-infrared photothermal agents for combined tumor immunotherapy and chemo-photothermal therapy","volume":"35","author":"Tao","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0050","first-page":"23","article-title":"Chemotherapy and immunotherapy: mapping the road ahead","volume":"39","author":"Cook","year":"2016","journal-title":"Nat. Rev. Clin. Oncol."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0055","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.immuni.2013.06.014","article-title":"Mechanism of actionof conventional and targeted anticancer therapies: reinstating immunosurveillance","volume":"39","author":"Zitvogel","year":"2013","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0060","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00262-012-1390-6","article-title":"Novel mechanism of synergistic effects of conventional chemotherapy and immune therapy of cancer","volume":"62","author":"Ramakrishnan","year":"2013","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0065","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/cdd.2013.67","article-title":"Immune-based mechanisms of cytotoxic chemotherapy: implications for the design of novel and rationale-based combined treatments against cancer","volume":"21","author":"Bracci","year":"2014","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0070","doi-asserted-by":"crossref","DOI":"10.1002\/adfm.201703303","article-title":"Nutlin-3a and cytokine Co-loaded spermine-modified acetalated dextran nanoparticles for Cancer chemo-Immunotherapy","volume":"27","author":"Bauleth-Ramos","year":"2017","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0075","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1126\/science.1252510","article-title":"The cellular and molecular origin of tumor-associated macrophages","volume":"344","author":"Franklin","year":"2014","journal-title":"Science"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0080","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.immuni.2014.06.010","article-title":"Tumor-Associated Macrophages: From Mechanisms to Therapy","volume":"41","author":"Noy","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0085","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1038\/ni.1937","article-title":"Macrophage plasticity and interaction with lymphocyte subsets: cancer as a paradigm","volume":"11","author":"Biswas","year":"2010","journal-title":"Nat. Immunol."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0090","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0095","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1158\/2159-8274.CD-10-0028","article-title":"Leukocyte complexity predicts breast cancer survival and functionally regulates response to chemotherapy","volume":"1","author":"DeNardo","year":"2011","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0100","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1158\/1078-0432.CCR-16-0133","article-title":"Molecular pathways: deciphering mechanisms of resistance to macrophage-targeted therapies","volume":"23","author":"Quail","year":"2017","journal-title":"Clin. Cancer Res."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0105","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.addr.2015.11.009","article-title":"Tumor-associated macrophages: potential therapeutic targets for anti-cancer therapy","volume":"99","author":"Komohara","year":"2016","journal-title":"Adv. Drug Delivery Rev."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0110","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1038\/nature21409","article-title":"Class IIa HDAC inhibition reduces breast tumours and metastases through anti-tumour macrophages","volume":"543","author":"Guerriero","year":"2017","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0115","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI59643","article-title":"Macrophage plasticity and polarization: in vivo Veritas","volume":"122","author":"Sica","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0120","doi-asserted-by":"crossref","first-page":"9963","DOI":"10.1016\/j.biomaterials.2014.08.036","article-title":"Immunostimulatory oligonucleotides-loaded cationic graphene oxide with photothermally enhanced immunogenicity for photothermal\/immune cancer therapy","volume":"35","author":"Tao","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0125","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1038\/nature09737","article-title":"Programming the magnitude and persistence of antibody responses with innate immunity","volume":"470","author":"Kasturi","year":"2011","journal-title":"Nature"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0130","doi-asserted-by":"crossref","first-page":"4629","DOI":"10.1158\/0008-5472.CAN-12-3058","article-title":"Tumor promotion by intratumoral plasmacytoid dendritic cells is reversed by TLR7 ligand treatment","volume":"73","author":"Le Mercier","year":"2013","journal-title":"Cancer Res."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0135","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S0092-8674(00)80412-2","article-title":"Minireview the virtues of a nonclonal system of recognition","volume":"91","author":"Medzhitov","year":"1998","journal-title":"Cell"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0140","first-page":"621","article-title":"Nat. Toll-like receptors and innate immunity","volume":"388","author":"Medzhitov","year":"2009","journal-title":"Rev. Immunol. (Paris)"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0145","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat. Med."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0150","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1016\/j.molmed.2010.08.001","article-title":"Small-molecule delivery by nanoparticles for anticancer therapy","volume":"16","author":"Chen","year":"2010","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0155","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1038\/nnano.2007.387","article-title":"Nanocarriers as an emerging platform for cancer therapy","volume":"2","author":"Peer","year":"2007","journal-title":"Nat. Nanotechnol."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0160","article-title":"A step-by-step multiple stimuli-responsive nanoplatform for enhancing combined chemo-photodynamic therapy","volume":"29","author":"Wang","year":"2017","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0165","doi-asserted-by":"crossref","first-page":"9518","DOI":"10.1021\/nn405674m","article-title":"Nanoparticles for combination drug therapy","volume":"7","author":"Ma","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0170","doi-asserted-by":"crossref","first-page":"17672","DOI":"10.1021\/acsami.8b04163","article-title":"Light-activated ROS-responsive nanoplatform codelivering apatinib and doxorubicin for enhanced chemo-photodynamic therapy of multidrug-resistant tumors","volume":"10","author":"Wei","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0175","doi-asserted-by":"crossref","first-page":"8266","DOI":"10.1002\/adfm.201603336","article-title":"Codelivery of a \u03c0\u2013\u03c0 stacked dual anticancer drug combination with nanocarriers for overcoming multidrug resistance and tumor metastasis","volume":"26","author":"Wei","year":"2016","journal-title":"Adv. Funct. Mater."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0180","doi-asserted-by":"crossref","first-page":"323","DOI":"10.4155\/tde.10.13","article-title":"Nanoparticle-assisted combination therapies for effective cancer treatment","volume":"1","author":"Hu","year":"2010","journal-title":"Ther. Delivery"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0185","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.jconrel.2017.03.395","article-title":"Targeting tumor associated macrophages (TAMs) via nanocarriers","volume":"254","author":"Singh","year":"2017","journal-title":"J. Control. Release"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0190","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1084\/jem.191.7.1117","article-title":"The cysteine-rich domain of the macrophage mannose receptor is a multispecific lectin that recognizes chondroitin sulfates A and B and sulfated oligosaccharides of blood group lewisa and lewisx types in addition to the sulfated N-glycans of lutropin","volume":"191","author":"Leteux","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0195","doi-asserted-by":"crossref","first-page":"15501","DOI":"10.1021\/ja406406h","article-title":"Phenylboronic acid-installed polymeric micelles for targeting sialylated epitopes in solid tumors","volume":"135","author":"Deshayes","year":"2013","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0200","doi-asserted-by":"crossref","first-page":"357","DOI":"10.7150\/thno.16855","article-title":"Systemic siRNA delivery with a dual pH-responsive and tumor-targeted nanovector for inhibiting tumor growth and spontaneous metastasis in orthotopic murine model of breast carcinoma","volume":"7","author":"Fan","year":"2017","journal-title":"Theranostics"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0205","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.ijpharm.2015.09.020","article-title":"Artemisinin nanoformulation suitable for intravenous injection: preparation, characterization and antimalarial activities","volume":"495","author":"Ibrahim","year":"2015","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0210","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1002\/smll.201201390","article-title":"Physicochemical characteristics of nanoparticles affect circulation, biodistribution, cellular internalization, and traffi cking","volume":"9","author":"Duan","year":"2013","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0215","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.1021\/cm5012718","article-title":"Dual-responsive polymer micelles for target-cell-specific anticancer drug delivery","volume":"26","author":"Guo","year":"2014","journal-title":"Chem. Mater."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0220","doi-asserted-by":"crossref","first-page":"6450","DOI":"10.1002\/adma.201502865","article-title":"Size changeable nanocarriers with nuclear targeting for effectively overcoming multidrug resistance in cancer therapy","volume":"27","author":"Guo","year":"2015","journal-title":"Adv. Mater."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0225","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/smll.201503292","article-title":"A nanoplatform with precise control over release of cargo for enhanced cancer therapy","volume":"12","author":"Qu","year":"2016","journal-title":"Small"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0230","doi-asserted-by":"crossref","first-page":"13193","DOI":"10.1038\/ncomms13193","article-title":"Photothermal therapy with immune-adjuvant nanoparticles together with checkpoint blockade for effective cancer immunotherapy","volume":"7","author":"Chen","year":"2016","journal-title":"Nat. Commun."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0235","doi-asserted-by":"crossref","first-page":"6646","DOI":"10.1073\/pnas.0631696100","article-title":"Molecular basis for the immunostimulatory activity of guanine nucleoside analogs: activation of Toll-like receptor 7","volume":"100","author":"Lee","year":"2003","journal-title":"Proc. Natl. Acad. Sci. U. S. A."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0240","doi-asserted-by":"crossref","first-page":"3138","DOI":"10.1002\/eji.201343801","article-title":"TLRs to cytokines: Mechanistic insights from the imiquimod mouse model of psoriasis","volume":"43","author":"Flutter","year":"2013","journal-title":"Eur. J. Immunol."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0245","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1084\/jem.191.7.1105","article-title":"Crystal structure of the cysteine-rich domain of mannose receptor complexed with a sulfated carbohydrate ligand","volume":"191","author":"Liu","year":"2000","journal-title":"J. Exp. Med."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0250","doi-asserted-by":"crossref","first-page":"4260","DOI":"10.1038\/s41388-018-0258-4","article-title":"Inactivation of the serine protease HTRA1 inhibits tumor growth by deregulating angiogenesis","volume":"37","author":"Klose","year":"2018","journal-title":"Oncogene"},{"key":"10.1016\/j.jconrel.2019.09.021_bib0255","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1158\/2159-8290.CD-14-0650","article-title":"NOTCH decoys that selectively block DLL\/NOTCH or JAG\/NOTCH disrupt angiogenesis by unique mechanisms to inhibit tumor growth","volume":"5","author":"Kangsamaksin","year":"2015","journal-title":"Cancer Discov."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0260","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1365-4632.2004.02318.x","article-title":"Imiquimod is a strong inhibitor of tumor cell-induced angiogenesis","volume":"44","author":"Majewski","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.jconrel.2019.09.021_bib0265","doi-asserted-by":"crossref","first-page":"4117","DOI":"10.1038\/onc.2011.567","article-title":"Breaking the \u2018harmony\u2019 of TNF-a signaling for cancer treatment","volume":"31","author":"Sasi","year":"2012","journal-title":"Oncogene"}],"container-title":["Journal of Controlled Release"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919305620?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0168365919305620?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T15:42:41Z","timestamp":1759160561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0168365919305620"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,11]]},"references-count":53,"alternative-id":["S0168365919305620"],"URL":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.09.021","relation":{},"ISSN":["0168-3659"],"issn-type":[{"value":"0168-3659","type":"print"}],"subject":[],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Selectively targeting tumor-associated macrophages and tumor cells with polymeric micelles for enhanced cancer chemo-immunotherapy","name":"articletitle","label":"Article Title"},{"value":"Journal of Controlled Release","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jconrel.2019.09.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}